The Huntington’s Post

News

WAVE PRECISION-HD Timing Update

MORE INFORMATION >

Amendment to the RG6042 Phase III GENERATION HD1 study design

MORE INFORMATION >

Roche Phase III GENERATION HD1 Study: Announcement of First European Countries/Expected Sites (Spain & UK)

MORE INFORMATION >

First HD patients enrolled in Roche/Genentech studies

MORE INFORMATION >

uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-130 in Huntington’s Disease

MORE INFORMATION >

You Pay the Higher Cost

MORE INFORMATION >

Holiday Gift Ideas

MORE INFORMATION >

Surviving the Holidays

MORE INFORMATION >

I Never Thought It Would Get Better, Either

MORE INFORMATION >